# Reviewer aiEs — Score: 4 (Accept)
**Confidence: 4 (High)**

## Strengths
- High clinical relevance (80% of trials fail enrollment timelines)
- Valuable benchmark without manual annotation
- End-to-end system design with strong real-world utility
- Smaller open-source models competitive (Gemma 2 9B within 2 points of best commercial)

## Weaknesses (mild)
- **W1: No human validation** at scale; LLM-as-judge confidence is limited
- **W2: RAG provides negligible improvement** over full-context for capable models — questions whether RAG is needed in the pipeline
